% | $
Quotes you view appear here for quick access.

St. Jude Medical Inc. Message Board

  • SortNewest  |  Oldest  |  Most Replied Expand all replies
    • News Breaks

      November 17, 2011
      12:35 EDT STJ

      St. Jude Medical falls after Bernstein releases negative survey results

      St. Jude Medical (STJ) is retreating after Bernstein conducted a survey which indicated that most relevant doctors are concerned about the insulation failures of St. Jude's Riata defibrillation leads.

      Specifically, 80% of high-volume implanting electrophysiologists have moderate to high levels of concern about the issue, according to the Bernstein survey.

      Another 40% of these doctors say that they've already reduced their use of St. Jude's ICD, or plan to do so.

      Finally, almost half of the doctors felt that St. Jude's Durata lead, which has remained on the market, could have the same problem as Riata, which has been discontinued.

      In the wake of this survey, Bernstein believes that the issue will impact St. Jude's market share. In early afternoon trading, St. Jude fell $1.79, or 4.58%, to $37.27.

76.20-1.59(-2.04%)Apr 29 4:01 PMEDT